Product information

Current status:

Cancelled Post Market

Current status date:

2009-10-30

Original market date: ^{See footnote 1}

1998-02-17

Product name:

PHL-CLONAZEPAM - 0.25MG

DIN:

02236947 Electronic product monograph is not available

Company:

PHARMEL INC
6111, Avenue Royalmount, Suite 100
Montreal
Quebec
Canada H4P 2T4

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Targeted (CDSA IV)

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:12.08 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N03AE01 CLONAZEPAM

Active ingredient group (AIG) number:^{See footnote5}

0111558003